AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 199 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,272 | -18.2% | 186 | 0.0% | 0.00% | – |
| Q4 2022 | $5,223 | +4.5% | 186 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | +25.0% | 186 | 0.0% | 0.00% | – |
| Q2 2022 | $4,000 | -20.0% | 186 | 0.0% | 0.00% | – |
| Q1 2022 | $5,000 | -16.7% | 186 | 0.0% | 0.00% | – |
| Q4 2021 | $6,000 | -33.3% | 186 | 0.0% | 0.00% | – |
| Q3 2021 | $9,000 | -10.0% | 186 | 0.0% | 0.00% | – |
| Q2 2021 | $10,000 | 0.0% | 186 | 0.0% | 0.00% | – |
| Q1 2021 | $10,000 | +25.0% | 186 | +1.6% | 0.00% | – |
| Q4 2020 | $8,000 | -90.2% | 183 | -89.3% | 0.00% | – |
| Q4 2019 | $82,000 | -99.8% | 1,709 | -99.8% | 0.00% | -100.0% |
| Q3 2019 | $35,113,000 | -34.8% | 1,083,694 | +0.4% | 0.04% | -29.8% |
| Q2 2019 | $53,862,000 | -8.4% | 1,079,829 | +23.8% | 0.06% | -10.9% |
| Q1 2019 | $58,822,000 | +47.9% | 872,225 | +1.1% | 0.06% | +23.1% |
| Q4 2018 | $39,779,000 | -23.1% | 862,715 | +28.7% | 0.05% | -7.1% |
| Q3 2018 | $51,705,000 | -2.0% | 670,443 | +7.0% | 0.06% | -1.8% |
| Q2 2018 | $52,779,000 | +10.9% | 626,603 | +7.6% | 0.06% | +1.8% |
| Q1 2018 | $47,607,000 | – | 582,141 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |